Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: The role of additional immune, genetic and metabolic markers of risk

Diabetologia

Volumn 49, Issue 5, 2006, Pages 881-890

  Bingley, P J ^a   Gale, E A M ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

ENDIT; First phase insulin response; HLA class II; Islet autoantibodies; Prediction; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA ANTIGEN CLASS 2; INSULIN; INSULIN ANTIBODY; OLIGONUCLEOTIDE; PANCREAS ISLET CELL ANTIBODY; PROTEIN TYROSINE PHOSPHATASE;

ADOLESCENT; ADULT; AGE; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENDER; GENETIC MARKER; GENOTYPE; GLUCOSE TOLERANCE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RELATIVE; RISK FACTOR; SCHOOL CHILD; SCREENING;

ADOLESCENT; ADULT; AGE OF ONSET; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; EUROPE; FEMALE; GENOTYPE; HLA-D ANTIGENS; HUMANS; INSULIN; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 33646401140     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0160-4     Document Type: Article

References (35)

1. Atkinson MA, Eisenbarth GS (2001) Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229
2. Bingley PJ, for the ICARUS Group (1996) Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Diabetes 45:1720-1728
3. Kulmala P, Savola K, Reijonen H et al (2000) Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Diabetes 49:48-58
4. The European Nicotinamide Diabetes Intervention Trial (ENDIT) group (2003) Intervening before the onset of type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia 46:339-346
5. The European Nicotinamide Diabetes Intervention Trial (ENDIT) group (2004) European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925-931
6. Diabetes Prevention Trial - Type 1 Diabetes Study Group (2002) Effects of insulin in relatives of patients with type 1 diabetes. N Engl J Med 346:1658-1691
7. Skyler JS, Krischer JP, Wolfsdorf J et al (2005) Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial - Type 1. Diabetes Care 28:1068-1076
8. World Health Organization (1985) Diabetes mellitus: report of a WHO study group. World Health Organization, Geneva
9. Bingley PJ, Colman PG, Eisenbarth GS et al (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15:93-102
10. Bingley PJ, Bonifacio E, Williams AJK, Genovese S, Bottazzo GF, Gale EAM (1997) Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 46:1701-1710
11. Verge CF, Stenger D, Bonifacio E et al (1998) Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 47:1857-1866
12. Undlien D, Friede T, Rammansee H-G et al (1997) HLA-encoded genetic predisposition in IDDM. DR4 subtypes may be associated with different degrees of protection. Diabetes 46:143-149
13. Andersen L, Dinesen B, Jørgensen PN, Poulsen F, Røder ME (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578-582
14. McCulloch DK, Bingley PJ, Colman PG, Jackson RA, Gale EAM, The ICARUS Group (1993) Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. Diabetes Care 16:911-915
15. Green A, Patterson CC, EURODIAB TIGER Study Group (2001) Trends in the incidence of childhood-onset diabetes in Europe 1989-1993. Diabetologia 44(Suppl 3):B3-B8
16. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, Laporte R, Tuomilehto J, Diabetes Mondiale (DiaMond) Project Group (2000) Incidence of childhood type 1 diabetes worldwide. Diabetes Care 23:1516-1526
17. Kondrashova A, Reunanen A, Romanov A et al (2005) A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med 37:67-72
18. Schoenle EJ, Lang-Muritano M, Gschwend S et al. (2001) Epidemiology of type 1 diabetes in Switzerland: steep rise in incidence in under 5 year old children in the past decade. Diabetologia 44:286-289
19. Collett D (1994) Modelling survival data in medical research. Chapman and Hall, London
20. Wicker LS, Todd JA, Peterson LB (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13:179-200
21. Bingley PJ, Williams AJK, Gale EAM (1999) Optimized autoantibody-based risk assessment in family members. Diabetes Care 22:1796-1801
22. Seissler J, Morgenthaler NG, Achenbach P et al (1996) Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. Diabetologia 39:1351-1356
23. Pastore MR, Bazzigaluppi E, Bonfanti R et al (1998) Two-step islet autoantibody screening for risk assessment of type 1 diabetes in relatives. Diabetes Care 21:1445-1450
24. Dittler J, Seidel D, Schenker M, Ziegler AG (1998) GADIA2-combi determination as first line screening for improved prediction of type 1 diabetes in relatives. Diabetes 47:592-597
25. Bingley PJ, Christie MR, Bonifacio E et al (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43:1304-1310
26. Verge CF, Gianani R, Kawasaki E et al (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 45:926-933
27. Kulmala P, Savola K, Petersen JS et al (1998) Prediction of insulin-dependent diabetes in siblings of children with diabetes. A population-based study. J Clin Invest 101:327-336
28. Christie MR, Roll U, Payton MA, Hatfield ECI, Ziegler AG (1997) Validity of screening for individuals at risk for type 1 diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20:965-970
29. Williams AJK, Bingley PJ, Moore WPT, Gale EAM, The ENDIT screening group (2002) Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with type 1 diabetes. Diabetologia 45:217-223
30. Decochez K, De Leeuw IH, Keymeulen B et al (2002) IA-2 antibodies predict impending type 1 diabetes in siblings of patients. Diabetologia 45:1658-1666
31. Achenbach P, Warncke K, Reiter J et al (2004) Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 53:384-392
32. Hoppu S, Harkonen T, Ronkainen MS, Akerblom HK, Knip M (2004) IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes. J Autoimmun 23:361-370
33. Hoppu S, Ronkainen MS, Kulmala P, Akerblom HK, Knip M (2004) GAD65 antibody isotypes and epitope recognition during the prediabetic process in siblings of children with type 1 diabetes. Clin Exp Immunol 136:120-128
34. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E (2004) Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 114:589-597
35. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661-1667